Gala vs MedVi: GLP-1 Cost & Plans Compared
Gala vs MedVi compared on price, medication format and commitment terms. See which GLP-1 programme fits, and what each actually costs over a year.
Quick Verdict
Editorial Take
Best Overall: Gala, on cost. Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to.
Best for Budget: Gala. Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to.
Best for Fast Approval: Both run fully online intake with licensed clinician review, so approval speed is unlikely to separate them. Gala quotes shipping as included in the plan; MedVi quotes free.
At a Glance Comparison
| Feature | Gala | MedVi |
|---|---|---|
| Semaglutide price | $179/month | $179/month |
| Tirzepatide price | $199/month | Not published before intake |
| Needle-free oral option | No | No |
| Brand-name medication | No | No |
| Insurance support | No | No |
| Shipping | Included in the plan | Free |
Who Should Choose Gala
Choose Gala if:
- ✓You want an unusually small gap between its semaglutide and tirzepatide pricing
- ✓You are comparing on a published semaglutide rate of $179/month
- ✓You accept the trade-off that semaglutide is expensive relative to the market
Who Should Choose MedVi
Choose MedVi if:
- ✓You want 24/7 access to certified medical professionals and same-day approval
- ✓You are comparing on a published semaglutide rate of $179/month
- ✓You accept the trade-off that semaglutide-only, with no tirzepatide pathway, and the promotional rate ends
Gala Deep Dive
Gala leads with an unusually small gap between its semaglutide and tirzepatide pricing. Semaglutide is published at $179/month, tirzepatide at $199/month. The honest caveat is that semaglutide is expensive relative to the market.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — included in the plan
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide from $179/month
- ✓Tirzepatide from $199/month
Pricing
$179/month semaglutide. Included in the plan.
- ✓An unusually small gap between its semaglutide and tirzepatide pricing
- ✓Included in the plan
- ✗Semaglutide is expensive relative to the market
- ✗Compounded medication is not an FDA-approved finished product
MedVi Deep Dive
MedVi leads with 24/7 access to certified medical professionals and same-day approval. Semaglutide is published at $179/month. The honest caveat is that semaglutide-only, with no tirzepatide pathway, and the promotional rate ends.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — free
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide from $179/month
Pricing
$179/month semaglutide, though the $179 rate is promotional; the regular rate is $299/month. Free.
- ✓24/7 access to certified medical professionals and same-day approval
- ✓Free
- ✗Semaglutide-only, with no tirzepatide pathway, and the promotional rate ends
- ✗Compounded medication is not an FDA-approved finished product
Honest Tradeoffs
Pricing
Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to.
Medication Types
Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Doctor Involvement
Both require review by a licensed U.S. clinician before dispensing, and neither is a subscribe-and-ship product. Ongoing support for dose titration is included at both.
Delivery Speed
Gala: Included in the plan. MedVi: Free. In practice the gap between clinician review times usually matters more than the shipping estimate.
Subscription Model
MedVi's advertised rate is conditional — the $179 rate is promotional; the regular rate is $299/month — whereas Gala's published rate does not require a prepaid term. Weigh the committed price against the flexible one.
Pricing Breakdown
| Aspect | Gala | MedVi |
|---|---|---|
| Semaglutide, monthly | $179/month | $179/month |
| Tirzepatide, monthly | $199/month | Not published before intake |
| 6-month semaglutide total | $1,074 | $1,074 |
| 12-month semaglutide total | $2,148 | $2,148 |
| Commitment required for best rate | No | Yes |
What You Actually Pay Over 12 Months
Advertised starting prices are the least useful number in this comparison, so below is what each provider costs across a realistic course of treatment rather than on day one. Pricing verified July 30, 2026; confirm the final figure at enrollment, as offers change.
| Gala | MedVi | |
|---|---|---|
| First month | $179/month | $179/month |
| 6-month total | $1,074 | $1,074 |
| 12-month total | $2,148 | $2,148 |
| Price includes | Medication, clinician review and ongoing dose support. Shipping: included in the plan. | Medication, clinician review and ongoing dose support. Shipping: free. |
| What can raise it | No prepaid term is required to reach the advertised rate. | The advertised rate is conditional — the $179 rate is promotional; the regular rate is $299/month. |
Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to. MedVi's advertised rate is conditional — the $179 rate is promotional; the regular rate is $299/month — whereas Gala's published rate does not require a prepaid term. Weigh the committed price against the flexible one. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Medication Comparison
Semaglutide
Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to.
Tirzepatide
Tirzepatide pricing is not published by both providers, so the dual-agonist comparison cannot be made from public information. Ask at intake if tirzepatide is what you want.
Which Provider Offers What
Both are injection-only, so if you want a needle-free tablet neither of these is the answer. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
Results Expectations
Safety Considerations
Side Effects
Both carry the GLP-1 side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, typically dose-related and most pronounced during titration. GLP-1 medications carry serious warnings including the risk of thyroid C-cell tumours and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Disclose your full history at intake.
Doctor Supervision
Both require review by a licensed U.S. clinician before dispensing and provide ongoing support for dose adjustment.
Prescription Requirement
Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.
How We Evaluated These Providers
We evaluated both providers based on the following criteria:
- ✓Published monthly pricing for each molecule, and the six and twelve-month totals that follow from it
- ✓Whether the advertised rate requires a prepaid term
- ✓Medication formats offered, including any needle-free option
- ✓Regulatory status: compounded against FDA-approved brand-name
- ✓Whether insurance can be used at all
- ✓Shipping as published by each provider
Final Verdict
Editorial Take
Best for Budget Users
Gala. Gala and MedVi both price semaglutide at $179/month, so price cannot decide this one and the programme around the medication has to.
Best for Fast Results
Tied, and neither should claim otherwise. Same molecules, comparable clinician-led process; the pace of results depends on titration and adherence rather than the provider.
Best for Doctor Supervision
Comparable. Both require licensed clinician review before dispensing and include ongoing dose support.
Best Premium Experience
Gala for an unusually small gap between its semaglutide and tirzepatide pricing; MedVi for 24/7 access to certified medical professionals and same-day approval. Which reads as premium depends on whether you value the programme around the medication or the lowest number on the invoice.
Frequently Asked Questions
Read Our Full Reviews
Related Comparisons
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.